Medical News

RSS

Innovative microscopic capsules overcome long-standing limitations in single-cell research

Researchers have developed a capsule-based method that makes it possible to analyse the same cell through multiple experimental steps.

12 Mar 2026

AI-generated meal plans for teens often lack essential nutrients and calories

Many teens dealing with weight issues are turning to AI models to help them create meal plans with the aim of losing weight.

12 Mar 2026

Adding three simple amino acids boosts mRNA and CRISPR delivery

Lipid nanoparticles, or LNPs, best known as the delivery vehicle for the COVID-19 mRNA vaccines received by billions of people, are now at the center of a much larger medical revolution.

12 Mar 2026

High-dose vitamin D3 does not reduce COVID-19 severity, but may impact long COVID outcomes

In a large, randomized trial, researchers at Mass General Brigham have found that high-dose vitamin D3 did not reduce COVID-19 infection severity, but may impact long COVID outcomes.

12 Mar 2026

Japanese study evaluates sleep architecture and safety of common insomnia drugs

OSA is a common sleep disorder characterized by oxygen desaturation due to repeated airway collapse during sleep.

12 Mar 2026

Personalized counseling program helps cervical cancer survivors quit smoking

A new study led by UCLA researchers suggests that a personalized counseling program can significantly help women who have survived cervical precancer or cervical cancer to quit smoking - and does so at a cost that researchers say represents good value for healthcare systems.

12 Mar 2026

New study identifies specific brain cells most vulnerable to ALS and dementia

Amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD) belong to a spectrum of neurodegenerative diseases with overlapping symptoms, characterized by muscle wasting, paralysis, dementia, and other serious impairments.

12 Mar 2026

Study reveals high burnout among doctors treating sickle cell disease

Hematology-oncology trained physicians who treat sickle cell disease reported higher rates of burnout (60%) than their counterparts who do not provide sickle cell care (43%) despite no differences in grit and resilience between the two groups.

12 Mar 2026

Father's nicotine use may increase diabetes risk for offspring

A mouse study found that a father's nicotine exposure can affect the offspring's ability to process sugar and may contribute to diabetes risk, according to new research published in the Journal of the Endocrine Society.

12 Mar 2026

Prebiotic fiber supplement lowers pain sensitivity in people with knee osteoarthritis

A new study has found that a prebiotic fiber supplement reduced pain, improved grip strength, and lowered pain sensitivity in people with knee osteoarthritis (OA) - with far fewer dropouts than a digital physiotherapy programme.

12 Mar 2026

Republicans fret over RFK Jr.’s anti-vaccine policies while MAHA moms stew

Health and Human Services Secretary Robert F. Kennedy Jr. is fielding pressure from the White House to relax his controversial approach to vaccine policies as the midterms near, but his most steadfast supporters are pressing for more aggressive action — like restricting covid-19 vaccines and pesticide use — to carry out the Make America Healthy Again agenda.

12 Mar 2026

VALANX Biotech secures €3 million to advance LIV-1 ADC for metastatic triple-negative breast cancer

VALANX Biotech (VALANX), a biotech company developing a technology for site-selectable, site-specific protein conjugation, today announced it has secured €3 million to advance its lead antibody-drug conjugate (ADC) program.

From VALANX Biotech 12 Mar 2026

As lung disease threatens workers, lawmakers seek protections for countertop manufacturers

César Manuel González, 37, used to work with stone that was engineered to endure: dense, polished slabs designed to outlast the kitchens in which they were installed.

12 Mar 2026

Combat Medical raises £2.6 million Series A to advance treatment of BCG unresponsive bladder cancer

Combat Medical (Combat), a medical device company optimizing the delivery and efficacy of cancer therapeutics, today announced it has raised £2.6 million in the first close of a Series A financing to advance its hyperthermic intravesical chemotherapy treatment, HIVEC® through phase 3 clinical trials and toward FDA registration.

From Combat Medical 12 Mar 2026